Jiun-Ming Wu

Title: Innovations of Jiun-Ming Wu in Vaccine Development

Introduction

Jiun-Ming Wu is a prominent inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of vaccine development, particularly in therapeutic vaccines for hepatitis B. With a total of four patents to his name, his work is paving the way for advancements in immunology.

Latest Patents

One of Jiun-Ming Wu's latest patents involves a fusion protein designed for use as a hepatitis B therapeutic vaccine. This fusion protein includes an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a protein transduction domain, and an antigen comprising a hepatitis B virus X protein deletion mutant. The protein transduction domain is a fusion polypeptide that contains a T cell sensitizing signal-transducing peptide, a linker, and a translocation peptide. The APC-binding domain or the CD91 receptor-binding domain is positioned at the N-terminus of the fusion protein, while the antigen is located at the C-terminus of the protein transduction domain.

Another notable patent focuses on vaccine compositions that aim to induce enhanced antigen-specific T cell-mediated immune responses. This composition includes a therapeutically effective amount of an immunogenic protein, a saponin-based adjuvant, and a Toll-like receptor (TLR) agonist adjuvant. These innovations are crucial for developing effective vaccines that can elicit strong immune responses.

Career Highlights

Jiun-Ming Wu is associated with Thevax Genetics Vaccine Co., Ltd., where he continues to work on groundbreaking vaccine technologies. His expertise in immunology and vaccine development has positioned him as a key figure in the industry.

Collaborations

He collaborates with notable colleagues, including Chia-Mao Wu and Wei-I Chou, who contribute to his research efforts and innovations in vaccine development.

Conclusion

Jiun-Ming Wu's contributions to vaccine technology, particularly in hepatitis B therapeutic vaccines, highlight his role as an influential inventor in the field. His innovative approaches and collaborations are essential for advancing immunological research and developing effective vaccines.